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Summary
Objective: To develop flow cytometry for the study of human articular cartilage cell phenotype and to validate the method on chondrocytes
cultured in different in-vitro systems.
Methods: Chondrocyte phenotype was modulated by culturing the cells under different in-vitro conditions: i.e. in monolayer and in suspension
culture in gelled agarose. Monolayer cultured chondrocyte phenotype was assayed by immunohistochemical staining with monoclonal
antibodies against chondrocyte-specific aggrecan, type II and I collagen. Flow cytometry was used to quantify the proportions of
chondrocytes expressing these extracellular matrix molecules in both culture conditions. To exclude the effects of cell-harvesting methods
on the presence of cell-bound ECM molecules, non-proteolytic isolation procedures were used to obtain the chondrocytes for flow cytometry.
Subconfluent cells from monolayer cultures were detached with EDTA. Chondrocytes cultured in gelled agarose were obtained after the
agarose was enzymatically digested with agarase.
Results: Immunohistochemical staining showed that monolayer-cultured chondrocytes, in the presence of serum, gradually lost the
expression of chondrocyte-specific aggrecan and type II collagen, while type I collagen was increasingly expressed. Flow cytometry allowed
monolayer cultured chondrocyte phenotype to be assessed reproducibly. Chondrocyte phenotype was characterized through the cell
membrane-associated extracellular matrix antigens. EDTA, used to obtain single cells from monolayer cultures, did not affect the
cell-associated matrix. Where the chondrocytes had been cultured in gelled agarose, flow cytometry allowed quantification of the
percentages of chondrocytes maintaining or reexpressing their original phenotype. The agarase digestion procedure used to isolate the cells
from the agarose gel did not affect the plasma membrane-associated extracellular matrix antigens.
Conclusion: Flow cytometry allows quantification of cells expressing aggrecan, type II and I collagen in their cell-associated extracellular
matrix. A continuously increasing number of specific monoclonal antibodies will broaden the range of applications offered by this method.
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Flow cytometry is used as a standard procedure to charac-
terize the phenotype of circulating lymphomyeloid cells. As
a consequence of the effects of any enzymatic digestion
procedure on plasma membrane antigens, the use of the
method is somewhat limited with cells isolated from tissues
or from culture. The availability of fluorescent agents has
enabled researchers to use flow cytometry mainly to study
chondrocytes on cell viability,1 proliferation and cell cycle
characteristics,2,3 respiratory activities and free radical pro-
duction.4 The availability of specific monoclonal antibodies
(Mabs) has enabled the use of flow cytometry to study
some plasma membrane-associated antigens, e.g.
cytokine receptors,5,6 cellular adhesion molecules,7,8 HLA
class I and II antigens,9 membrane-bound peptidases10
and intracellular cytokines.11 Exceptionally, flow cytometry73has been used to study the synthesis of extracellular matrix
(ECM) molecules.12
Articular cartilage is composed of a hydrated extensive
ECM in which chondrocytes are embedded. Chondrocytes
contact the matrix through numerous cytoplasmic pro-
cesses rich in microfilaments as well as through specific
plasma membrane molecules. The cell-associated matrix is
characterized by a high content of large proteoglycan
aggregates bound to the cell via the interaction of hyaluro-
nan with CD44-like receptors.13 Chondrocyte cell mem-
branes also exhibit several proteins with binding affinity for
collagen, including anchorin CII,14 heparan sulfate proteo-
glycan14,15 and chondronectin.16 This enables the use of
flow cytometry to study the expression of the ECM macro-
molecules belonging to the pericellular domain of the
chondrocytes. The presence or absence of chondrocyte-
specific aggrecan and collagens could then be used as
phenotypic markers of cartilage cells maintained in different
in-vitro conditions.
The use of isolated chondrocytes in in-vitro culture
systems has allowed the study of synthesis and turnover of
the ECM of articular cartilage under a variety of influencing
factors. A correct interpretation of chondrocyte function on
results obtained in vitro remains difficult since chondro-
cytes have been shown to lose their original phenotype
when maintained in certain in-vitro culture systems. Apart
74 L. Wang et al.: Flow cytometry of chondrocytesMaterials and methods
ISOLATION OF CHONDROCYTES
Human articular chondrocytes were isolated as
described elsewhere,31,32 with a few modifications.
Articular cartilage was obtained at autopsy from 21 different
donors within 24 h post mortem (14 men, seven women;
aged from 1 to 72 years). All donors had died after a short
illness. None received corticosteroids or cytostatic drugs.
Visually intact cartilage was sampled from the femur con-
dyles, diced into small fragments and digested in a spinner
bottle. All enzymatic solutions were made in Dulbecco’s
modified Eagle’s medium (DMEM; GIBCO BRL, Grand
Island, NY) with antibiotics and antimycotics (penicillin
10 U/ml; streptomycin 10 mg/ml; fungizone 0.025 mg/ml;
GIBCO BRL), 0.002 M/ml L-glutamine and 10% of fetal calf
serum (FCS; GIBCO BRL) when specified.
Articular cartilage was treated with 0.25% of sheep
testes hyaluronidase (Sigma, St Louis, MO, U.S.A.) in
DMEM for 120 min at 37°C. The hyaluronidase solution
was then replaced by 0.25% of Pronase (Streptomyces
griseus Pronase E; Sigma) in DMEM for 90 min at 37°C.
The cartilage was then washed twice with DMEM contain-
ing 10% FCS and stored overnight in the same incubation
medium at 37°C. The tissue was solubilized the next day
following 3–6 h 0.25% collagenase (Clostridium histo-
lyticum; Sigma) treatment in DMEM with 10% FCS at 37°C.
Cells were then centrifuged for 10 min at 800 g, washed
three times with DMEM with FCS, tested for viability
(Trypan Blue exclusion test) and counted. Usually,
150×106 chondrocytes could be obtained from femoral
condyles of one individual. More than 95% of the cells were
viable after isolation.MONOLAYER CULTURE OF CHONDROCYTES
For immunohistochemistry, LAB-TEK® Permanox
Chamber Slides (Nalge Nunc International, Naperville, IL,
U.S.A.) were first coated with poly-L-lysine (0.01% solution,
Sigma). A volume of 0.9 ml of medium containing 4.0×104isolated chondrocytes were then seeded in each 1.5 cm2
chamber. The 1.5 cm2 of the chambers provided enough
surface area to allow 4.0×104 isolated chondrocytes to
proliferate in the media specified. DMEM supplemented
with 10% FCS was used as a medium when dediffer-
entiation of the cells was studied. Serum-free DMEM
supplemented with bovine pancreas insulin at 100 ng/ml
(Boehringer Mannheim, Indianapolis, IN), human serum
transferrin at 100 g/ml (Boehringer Mannheim) and TGF-
at 50 ng/ml (R&D Systems, Minneapolis, MN) was used
when the chondrocytes had to maintain the original pheno-
type. These three factors at the concentrations mentioned
were found to ensure optimal aggrecan synthesis rates by
chondrocytes cultured in gelled agarose in the absence of
serum.33
The cultures were placed at 37°C in a humidified 5%
CO2 atmosphere and the media were changed twice a
week. The cultures in FCS were stopped after about one
week when the cells were subconfluent. Chondrocytes in
serum-free media supplemented with insulin, transferrin
and TGF- were held in culture for 2 weeks. Then the
media in the chambers were removed and the Permanox
Slides with the attached cultured cells were allowed to dry
in the air before storing at 4°C.
To prepare cultures for flow cytometric analysis, isolated
cells (1.0×106 cells in 4 ml of medium) were seeded in
50 mm diameter culture dishes (six-well culture plates;
Nunc, Roskilde, Denmark). DMEM containing 10% of FCS
was used as a nutrient medium and was replaced three
times per week. Confluent cultures were dissociated with
0.1% (w/v) of trypsin (Sigma) in Hanks balanced salt
solution (HBSS) without Ca+ +/Mg+ + (GIBCO BRL) to make
subcultures. Where cells were harvested for flow cytometry,
subconfluent cells from primary cultures or subcultures
were detached with 1 mmol/l EDTA in HBSS without Ca+ +/
Mg+ + for 30 min. The limitation of EDTA treatment is the
difficulty of dissociating confluent monolayer cultured
chondrocytes embedded in a dense matrix. Chondrocytes
were therefore seeded in low-density cultures and pheno-
types were defined after 4 days in subconfluent cultures.
This procedure made it possible to obtain single cells
embedded in a cell-associated matrix (CAM).CHONDROCYTES IN AGAROSE CULTURE
Chondrocytes were cultured in gelled agarose as pre-
viously described22 with some modifications.24,34 The cul-
tures were set up in 3.8 ml cryotubes (Nunc). The agarose
used was ultralow gelling temperature agarose. Three per
cent agarose in distilled water was autoclaved twice for
15 min and stored at 4–8°C. The cryotubes were coated
with 100 l of this 3% agarose and the coating was then
allowed to gel at 4–8°C. Chondrocyte suspension cultures
were established in 1.5% agarose concentrations. Three
per cent (double concentrated) agarose gel was melted
before use, kept at 37°C and mixed with an equal volume of
2× DMEM [for 50 ml of 2× DMEM: 1.337 g of lyophilized
DMEM (GIBCO BRL), 0.37 g of NaHCO3 and 5 mg of
ascorbate in 40 ml distilled water and 10 ml FCS; to
sterilize through a 0.22 m pore membrane filter] to give
the desired concentration of agarose in DMEM with 10% of
FCS.
0.1 vol. of the chondrocyte suspension was added to
1 vol. of soluble agarose in DMEM. Coated cryotubes were
filled with 300 l of chondrocytes/agarose suspension and
kept at 4–8°C for 15 min to allow the agarose to gel. Thefrom the influences of growth and differentiation factors, the
physical environment also decides the ultimate phenotype
of the cells. Articular cartilage cells, when propagated in
monolayer culture, have been shown to lose their
original phenotype and to dedifferentiate to fibroblast-like
cells.17–19 It was previously shown that monolayer-cultured
‘dedifferentiating’ fibroblast-like chondrocytes secrete
increasing proportions of hyaluronan and significantly
decrease the synthesis of their chondrocyte type of aggre-
can.18 Some serum factors modulate the chondrocytes
towards the fibroblast phenotype.20 Propagation of these
cells in serum-free incubation media allows the original
morphology and function to be maintained.21 It was also
reported that propagation of chondrocytes in the monolayer
condition in serum-free incubation media, or culture of
these cells in gelled artificial matrices, e.g. agarose,22–24
alginate,25,26 collagen,27,28 and in polyglycolic–polylactic
acid29,30 allowed the original morphology and in-vivo func-
tion to be maintained.18,21 We have used some of these
culture conditions where chondrocytes maintain or lose
their differentiated phenotype to explore the possibilities
of flow cytometric assessment of the status of the cells.
Immunohistochemistry was used before the flow cytometric
analysis was performed.
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per culture. Three millilitres of DMEM containing 10% FCS
plus 50 g/ml freshly dissolved ascorbate were then added
and the cultures were placed in an incubator at 37°C under
5% CO2 for 2 weeks. Nutrient medium was replaced twice
a week.
One or two weeks after culture the agarose was
dissolved with 2.0 ml of 50 U/ml agarase (agarose
3-glycanohydrolase from Pseudomonas Atlantica, Sigma)
in phosphate-buffered saline (PBS, GIBCO BRL) at 37°C
for 1 h. The cell suspension was washed twice with PBS
before flow cytometric analysis.MONOCLONAL ANTIBODIES (MABS)
Mabs against different extracellular matrix (ECM)
molecules, which included mouse anti-human chondrocyte-
specific aggrecan,35 type I and type II collagen,36 were
selected (Table I). Mouse IgG1 or IgG2a were used as
isotype-matched negative controls.
The anti-human chondrocyte-specific aggrecan Mab was
shown to react specifically with the G1-domain of the
invariable hyaluronan-binding region of the human aggre-
can molecule. No cross-reactivity with other known matrix
components could be detected.35,37 Anti-human type I
and II collagen Mabs were raised in BALB/c mice after
immunization with human placental type I collagen and
type II collagen from human costal cartilage, respectively.
On Western Blots anti-type I collagen was shown to
specifically react with the -chains and the triple helix
molecular form of type I collagen, and the anti-type II
collagen Mab specifically reacted with the 2(II) chain of
36type II collagen.IMMUNOHISTOCHEMICAL STAINING
After fixation with diluted Acetone (3:2 Acetone:PBS) for
10 min, the slides covered with the cells were incubated
with 3% hydrogen peroxide for 5 min to quench endoge-
nous peroxidase activity. The slides were then incubated
for 30 min with the primary antibodies against aggrecan,
type I or type II collagen (working titre 1:2000) and the
substrate-bound antibodies were visualized using biotin-
ylated secondary antibodies, peroxidase-labeled strepta-
vidin and a substrate-chromogen solution which consisted
of 3-amino-9-ethylcarbazole (Labelled Streptavidin Biotin
Kit, LSAB®+ Kit; DAKO, Glostrup, Denmark). The incu-
bation periods were 15, 15 and 10 min, respectively. Nuclei
were counterstained with hematoxylin. As a negative con-
trol, the primary antibodies were replaced either by isotype-
matched mouse IgG1 or IgG2a (DAKO). The stains were
evaluated using a semi-quantitative score (− up to + + +),
representing the approximate percentage of the labeled
cells observed under the light microscope (−: 0–5%; +:
6–40%; + +: 41–70%; + + +: 71–100%).PREPARATION OF FITC-CONJUGATED MABS FOR FLOW
CYTOMETRY
For the use of direct immunofluorescent staining in flow
cytometry, the monoclonal antibodies and the isotype
matched control antibodies were first conjugated with FITC
(Fluorescein isothiocyanate, Isomer I, Sigma) according to
the method of Wood et al.38 with some modifications.
Briefly, 1 mg/ml of the antibody was mixed with FITC
(0.2 mg/ml) in a conjugation buffer (0.5 M carbonate/
bicarbonate buffer, pH 9.5) and kept in the dark at 4°C
overnight. Conjugated antibody was separated from
free FITC using Sephadex G-25 (Pharmacia, Uppsala,
Sweden) gel permeation chromatography in a PBS solution
at pH 7.2. The optical density of the FITC-conjugated
antibodies was measured at 495 nm (FITC) and 280 nm
(protein) by spectrometry (Ultrospec® 1000E, Pharmacia
Biotech, Cambridge, U.K.). The degree of conjugation was
calculated according to the following equation:
Antibody:FITC=(2.87×A495)/(A280−0.35×A495).
Optimal conjugation requires a ratio between 3 and 5.
Conjugated antibodies were stored at 4°C, in the dark, with
0.01% (w/v) sodium azide.FLOW CYTOMETRIC ANALYSIS
About 2×105 chondrocytes isolated from monolayer cul-
tures or from the agarose gels were resuspended in 100 l
of PBS, containing 0.1% sodium azide and 0.2% bovine
serum albumin. The cells were incubated with FITC-
conjugated Mabs or negative controls in the dark for 30 min
at 4°C and then washed with PBS before flow cytometer
analysis (FACSort, Becton Dickinson, San Jose, CA,
U.S.A.) with CELLQuest software. From each sample,
20 000 events were analyzed. Dead cells were excluded by
propidium iodide (PI, Sigma) staining. PI binds to DNA in
dead cells with an unintact plasma membrane. Cells were
gated on forward and side scatter to exclude debris and cell
aggregates. The flow cytometric setting was identical
throughout the whole study. To calculate the percentages of
cells staining with the antigen-specific FITC-Mabs, the
interface channel for positivity was set at the point where
less than 2% of the control fluorescence (cells exposed to
isotype matched FITC-mouse IgG) was positive.Table I
Monoclonal antibodies
Clone Isotype Source
Aggrecan AD11-2A9 IgG1 Biosource Europe, Nivelles, Belgium
Type I collagen I-8H5 IgG2a ICN Biochemicals, Ohio, U.S.A.
Type II collagen II-4C11 IgG1 ICN Biochemicals, Ohio, U.S.A.REPRODUCIBILITY TESTS
To evaluate the reproducibility of the flow cytometry
assays, the method was tested on aliquots of cells obtained
from the same culture. After 1 week of culture, cells
obtained from one single monolayer and from one single
agarose culture were tested in fourfold for the presence of
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variation were calculated to evaluate the reproducibility
of the flow cytometry assay.
To study the reliability of the whole procedure, cells from
the same donor were cultured separately in four monolayer
and four agarose cultures. The same epitopes were
assayed after one week of culture under identical in-vitro
conditions. Coefficients of variation were calculated to
estimate the reliability of the values obtained for the
presence of the respective cell-bound epitopes.THE INFLUENCE OF THE ISOLATION PROCEDURES ON THE
DETECTION OF CELL BOUND MOLECULES
In order to exclude the effects of the isolation methods
on the presence of cell-bound ECM molecules, isolated
chondrocytes were analyzed by flow cytometry before and
after exposure to EDTA or agarase.
To test the effect of agarase, subconfluent monolayer
cultured cells were detached after 4 days of culture with
1 mmol/l EDTA in HBSS without Ca+ +/Mg+ + for 30 min and
harvested. The expression of aggrecan, type II and type I
collagen was tested on the isolated cells before and after
the exposure to 50 U/ml of agarase at 37°C for 1 h.
To test the effect of EDTA, chondrocytes were obtained
from 1-week-old agarose cultures after digestion of the
agarose gel with agarase. The expression of aggrecan,
type II and type I collagen was tested on the isolated cells
before and after exposure to 1 mmol/l EDTA in HBSS
without Ca+ +/Mg+ + for 30 min.MODULATION OF CHONDROCYTE PHENOTYPE IN PRIMARY AND
SECONDARY CULTURE IN DIFFERENT CULTURE CONDITIONS
In order to illustrate the maintenance, or the loss of the
original phenotype over long periods of time, primary
chondrocyte cultures were established either in gelled
agarose, or in the monolayer condition as described.
DMEM with 10% of FCS was used as a nutrient medium in
the two culture conditions. After 1, 2, 3 and 4 weeks, the
chondrocytes were liberated from the agarose matrix using
the agarase digestion procedure, and from the culture
dishes using the EDTA dissociation procedure. Their cell-
bound ECM molecules were then tested by flow cytometry.
The potential to re-express the chondrocyte phenotype
was studied in chondrocytes that had first dedifferentiated
in primary monolayer culture in DMEM supplemented with
10% FCS. After having been harvested from the culture
dishes with 0.1% (w/v) of trypsin (Sigma) in HBSS without
Ca+ +/Mg+ +, the cells were used to make secondary cul-
tures in either gelled agarose or again in the monolayer
condition. DMEM with 10% of FCS was used as a nutrient
medium throughout the experiment. The presence of cell-
bound ECM molecules was investigated by flow cytometry
immediately after the isolation of the cells from the primary
cultures with trypsin (time 0), and after 12 hours, 1, 2, 4 and
6 days of culture in gelled agarose or as monolayers.STATISTICS
Median values and the lower and upper quartiles were
calculated for the proportions of Mab-stained cells obtained
after culture in different in-vitro conditions. Differences in
the expression of the various ECM compounds chondro-cytes at different time points by chondrocytes cultured in
monolayer and in agarose, as well as differences in the
expression of matrix compounds in the two culture sys-
tems, were analyzed with the two-tailed Wilcoxon test for
paired samples. The significance level for all tests was set
at P=0.05.ResultsIMMUNOHISTOCHEMICAL STAINING OF MONOLAYER CULTURED
CELLS
Cells cultured in medium containing 10% FCS rapidly
lost their original morphology and dedifferentiated to
fibroblast-like cells, while the cells cultured in serum-free
media supplemented with insulin, transferrin and TGF-
remained oval and grew in clusters (Fig. 1). The results of
the immunohistochemical staining procedure were sum-
marized in Table II. More than 50% of the chondrocytes
maintained under serum-free conditions in the presence of
insulin, transferrin and TGF- expressed chondrocyte-
specific human aggrecan and type II collagen. When the
same cells were grown in DMEM supplemented with FCS,
the proportions of cells expressing aggrecan and type II
collagen decreased and in some of the cultures the
chondrocytes completely failed to synthesize type II colla-
gen. Staining for type I collagen was seen in variable
proportions (6–70%) of the cells cultured in DMEM with
10% of FCS, whereas all but one of the chondrocyte
cultures in TGF- supplemented serum-free medium failed
to produce type I collagen. The semi-quantitative nature of
the data did not allow proper statistical analysis.FLOW CYTOMETRIC ANALYSIS
A typical flow cytometry dot blot is shown in Fig. 2. The
chondrocytes in this experiment were obtained from a
55-year-old woman and harvested after 1 week of
primary culture in gelled agarose. After their isolation from
the agarose, a two-parameter dot blot of the cells was
performed following PI staining to exclude the dead cells.
According to their size (forward scatter) and their
PI-staining, the cells separated on these two-dimensional
blots into three groups: PI-positive dead cells, PI-negative
debris and PI-negative living cells. The population of
single living cells was analyzed for their expression of
the investigated extracellular matrix compounds. Flow
cytometry histograms representing the proportions of
chondrocytes staining for aggrecan, type II and I collagen
are shown in Fig. 2. Percentages of positive (Mab-stained)
cells were defined by comparison with the negative con-
trol cells which were non-specifically stained after the
incubation with the isotype-matched IgG.REPRODUCIBILITY AND RELIABILITY OF FLOW CYTOMETRY
To evaluate the reproducibility of the method, chondro-
cytes obtained from a 55-year-old woman were cultured in
one single monolayer culture. After 1 week, the sub-
confluent cells were dissociated with EDTA and tested in
fourfold for the presence of cell-bound ECM molecules. The
coefficient of variation of the assay for aggrecan, type II and
type I collagen was 3.8%, 13.2% and 2.5%, respectively
[Table III(a); interassay variability]. The same procedure
was repeated with a sample of third-passage monolayer-
cultured chondrocytes obtained from a 19-year-old man
which were subcultured in agarose. After 1 week, the
agarose matrix was digested with agarase to isolate the
cells which were tested in fourfold for the presence of
cell-bound ECM epitopes. Coefficients of variation of the
assay for aggrecan, type II and type I collagen were 6.1%,
11.0% and 2.6%, respectively [Table III(b); interassay
variability].
The reliability of the whole procedure was also tested on
aliquots of four chondrocyte monolayers originating from
the same donor but cultured separately [Table III(a); inter-
culture variability]. Chondrocytes obtained from a 55-year-
old woman were cultured in four separate monolayer
cultures. After 1 week, the subconﬂuent cells were dissoci-
ated with EDTA and tested for the presence of cell-bound
ECM molecules. Coefficients of variation of the assay for
aggrecan, type II and type I collagen were 2.2%, 18.8% and
9.0%, respectively. The same procedure was repeated with
a sample of second-passage monolayer-cultured chondro-
cytes obtained from a 40-year-old man which were sub-
cultured in four separate agarose cultures. After 1 week,
the agarose matrix was digested with agarase to isolate the
cells which were tested for the presence of cell-bound ECM
epitopes. Coefficients of variation of the assay for aggre-
can, type II and type I collagen were 10.2%, 6.3% and
8.0%, respectively [Table III(b); interculture variability].
INFLUENCE OF ISOLATION METHODS ON THE DETECTION OF
CELL-BOUND ECM MOLECULES
To test whether or not treatment of the cells with EDTA
altered the presence of the cell-bound matrix antigens,
chondrocytes cultured in agarose were released from the
gel with agarase. Proportions of cells recognized by anti-
aggrecan, anti-type II and I collagen Mabs did not change
signiﬁcantly after a 30 min exposure to 1 mmol/l EDTA in
HBSS without Ca+ +/Mg+ + (Table IV). The small percen-
tages of cells presenting type I collagen caused rather
high proportional changes to be calculated in two of the
experiments. However, only small absolute changes in
the expression of this collagen were noted after EDTA
treatment.
Fig. 1. Immunohistochemical staining of monolayer-cultured chondrocytes on Permanox chamber slides. (A) Staining against aggrecan,
type II and type I collagen of cells cultured in TGF-, insulin and transferrin supplemented DMEM for 2 weeks. (B) Staining against aggrecan,
type II and type I collagen of cells cultured in 10% FCS supplemented DMEM for 1 week.
Table II
Patterns of immunohistochemical staining of chondrocytes cul-







F44 TGF-† + + + + −
FCS‡ + − +
M33 TGF- + + + + −
FCS + + + + +
F72 TGF- + + + + −
FCS + + + +
M1 TGF- + + + + −
FCS + + + +
M2 TGF- + + + + +
FCS + − + +
Stains were evaluated using a semiquantitative score (− up to
+ + +), representing the approximate percentage of the labeled
cells observed under the light microscope (−: 0–5%; +: 6–40%;
+ +: 41–70%; + + +: 71–100%).
*Sex (F: female, M: male) and age are given.
†Cultures in DMEM supplemented with insulin, transferrin and
TGF-.
‡Cultures in DMEM supplemented with FCS.
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altered the expression of the cell-bound matrix antigens,
monolayer-cultured chondrocytes were released from the
culture dishes with 1 mmol/l EDTA in HBSS without Ca+ +/
Mg+ + and then treated with agarase at 37°C for 1 h.
Proportions of cells recognized by anti-aggrecan, anti-type
II and I collagen Mabs did not change after exposure to
agarase (Table V).
CHONDROCYTE PHENOTYPE IN THE MONOLAYER CONDITION
The percentage of cells staining positively with Mabs
against chondrocyte-specific aggrecan, type II and type I
collagen in primary cultures and after different passages
are shown in Table VI. Median values for the percentage of
cells staining for aggrecan and type II collagen decreased
from 52.3% to 15.7% (P<0.01) and from 45.4% to 20.5%
(P<0.01), respectively. The expression of type I collagen
increased from 21.2% of the chondrocytes in primary
cultures to 30.9% (P<0.01) of the cells after a first passage.
The median value for the ratio of type II/I collagen was
higher in primary than in secondary cultures (2.38 vs 0.65,
P<0.01). This loss of the original phenotype became more
pronounced when tertiary cultures were investigated in
seven donors (Table VI).Fig. 2. Flow cytometric analysis of human chondrocytes. Donor:
55-year-old woman. Cells were harvested after 1 week of primary
culture in gelled agarose. Top: dot plot of human chondrocytes
after propidium iodide (PI) staining. R1: region 1: PI-positive, dead
cells; R2: region 2: PI-negative, debris; R3: region 3: PI-negative,
living cells. Bottom: histograms showing the expression of A-
aggrecan, B-type II collagen, C-type I collagen. Grey curves:
negative controls; Black curves: Mab-FITC labeled cells.CHONDROCYTES IN AGAROSE GEL SUSPENSION CULTURE
Chondrocytes from eight different donors were used to
make primary chondrocyte cultures in both gelled agarose
and in monolayer culture. DMEM with 10% of FCS was
used as a nutrient medium in both culture conditions. After
1 week of culture the cells were harvested using the
appropriate procedures and the presence of the cell-bound
ECM molecules was studied by flow cytometry. Results of
phenotypic characterization of the chondrocytes are shown
in Table VII. Significant differences in phenotype occurred
in the two different culture systems.
Median values for percentages of cells expressing
aggrecan were 67.9% and 32.0% in agarose and in mono-
layer cultures, respectively (P<0.01). Type II collagen was
expressed by 58.6% of the cells in agarose and by 23.3%
of the monolayer cultured cells (P<0.01). 17.4% of the
chondrocytes expressed cell-bound type I collagen in
agarose and 26.7% of the chondrocytes did so in mono-
layer culture (P<0.2). Without exception, decreasing pro-
portions of chondrocytes expressed aggrecan and type II
collagen in monolayer culture. All but one chondrocyte
sample expressed less type I collagen in monolayer
culture.
Important variations in the percentages of cells staining
for both the chondrocyte-specific ECM antigens were
observed where chondrocytes obtained from different
donors were studied. Lowest and highest values obtained
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can in gelled agarose were 53.0% and 82.2%. Expression
of type II collagen by these primary chondrocytes in the
same culture condition varied between 35.3% and 78.5%.
The positive expression of both type I and II collagens was
less than 100% in most of the primary chondrocytes.
Variable proportions of the cells thus did not express
collagen.CHANGES IN CHONDROCYTE PHENOTYPE DURING PROLONGED
PRIMARY CULTURE IN THE MONOLAYER CONDITION AND IN
SUSPENSION CULTURE
The loss of the differentiated phenotype was well
illustrated when chondrocytes were maintained in primaryTable IV
Chondrocyte phenotype before and after treatment with EDTA
Percentage of positive cells
Aggrecan Collagen II Collagen I
M40
Before 88.4 87.9 43.3
After 84.8 85.9 32.7
% change −4.1% −2.3% −24.5%
M25
Before 94.0 79.4 6.1
After 90.6 79.6 7.7
% change −3.6% +0.3% +26.2%
F28
Before 76.5 20.3 8.1
After 72.0 22.9 9.8
% change −5.9% +12.8% +21.0%
M40: 40-year-old man, M25: 25-year-old man, F28: 28-year-old
woman. Primary cultures were established in agarose and the cells
were harvested after 1 week to test the effects of EDTA.Table V
Detection of cell-bound ECM molecules before and after digestion
with agarase
Percentage of positive cells CII/CI
Aggrecan Collagen II Collagen I
M65
Before 57.7 54.9 12.9 4.26
After 54.6 56.4 13.6 4.15
% change −5.4% +2.7% +5.4% −2.6%
M40
Before 2.8 7.1 15.4 0.46
After 3.0 7.4 15.2 0.49
% change +7.1% +4.2% −1.3% +6.5%
M25
Before 7.8 9.6 12.5 0.77
After 6.0 9.7 12.9 0.75
% change −23.1% +1.0% +3.2% −2.6%
M65: 65-year-old man, primary monolayer culture; M40:
40-year-old man and M28: 28-year-old man, third passage mono-
layer cultures. Monolayer cultures were established and the cells
were harvested after 4 days to test the effects of agarose. CII/CI:
type II/I collagen ratio.Table III(a)
Reproducibility of flow cytometric analysis of human cartilage chondrocytes in monolayer culture
1 2 3 4 X±S.D. CV
Interassay variability
Aggrecan 64.6 63.5 68.8 67.8 66.2±2.5 3.8%
Type II collagen 11.5 15.1 15.6 15.3 14.4±1.9 13.2%
Type I collagen 26.7 26.0 25.3 25.4 25.9±0.6 2.5%
Interculture variability
Aggrecan 66.2 64.6 68.2 66.8 66.5±1.5 2.2%
Type II collagen 14.4 15.1 17.3 10.7 14.4±2.7 18.8%
Type I collagen 25.9 22.1 23.2 26.8 24.5±2.2 9.0%
55-year-old woman; cells were tested after 4–7 days in primary monolayer culture; X±S.D.: mean±1 standard
deviation; CV: coefficient of variation=1 S.D.×100/X.
Table III(b)
Reproducibility of flow cytometric analysis of human cartilage chondrocytes in agarose culture
1 2 3 4 X±S.D. CV
Interassay variability
Aggrecan 14.2 15.1 15.7 13.8 14.7±0.9 6.1%
Type II collagen 37.0 42.6 36.2 32.8 37.2±4.1 11.0%
Type I collagen 54.4 53.9 51.7 52.9 53.2±1.2 2.6%
Interculture variability
Aggrecan 22.2 24.4 20.0 19.6 21.6±2.2 10.2%
Type II collagen 21.2 24.3 22.6 21.4 22.4±1.4 6.3%
Type I collagen 23.6 26.7 28.5 25.5 26.1±2.1 8.0%
Chondrocytes were obtained from two different donors.
Interassay variability: 19-year-old man; 3rd passage monolayer-cultured chondrocytes were subcultured in
agarose and tested after one week in agarose culture.
Interculture variability: 40-year-old man; 2nd passage monolayer-cultured chondrocytes were subcultured in
agarose and tested after one week in agarose culture.
X±S.D.: mean±1 standard deviation; CV: coefficient of variation=1 S.D.×100/X.
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Flow cytometric analysis of chondrocyte phenotype in monolayer culture
Male/female, age Culture period Percentage of cells expressing CII/CI
Aggrecan Collagen II Collagen I
M65 Primary 64.0 57.1 19.4 2.94
Secondary 29.7 11.8 26.8 0.44
F65 Primary 47.4 68.0 5.0 13.60
Secondary 16.1 23.0 26.1 0.88
M16 Primary 82.5 50.4 17.5 2.88
Secondary 54.4 25.0 50.6 0.49
M58 Primary 81.0 38.1 16.9 2.25
Secondary 56.0 18.2 18.7 0.92
M23 Primary 52.3 43.8 18.4 2.38
Secondary 7.0 29.2 30.9 0.94
M48 Primary 54.7 45.4 26.6 1.71
Secondary 38.8 20.5 47.9 0.43
F55 Primary 66.2 14.4 25.9 0.56
Secondary 29.0 17.1 26.3 0.65
Tertiary 7.3 17.6 28.6 0.62
F27 Primary 33.1 27.3 30.9 0.88
Secondary 1.5 21.5 30.9 0.70
Tertiary 0.9 18.3 78.2 0.23
M31 Primary 65.6 48.8 28.4 1.72
Secondary 12.8 46.3 34.3 1.35
Tertiary 3.4 23.1 47.7 0.48
M40 Primary 24.4 24.1 8.6 2.80
Secondary 7.8 26.1 28.6 0.91
Tertiary 3.6 23.4 40.8 0.57
M25 Primary 28.7 59.5 21.2 2.81
Secondary 7.5 16.9 36.9 0.46
Tertiary 6.9 9.6 38.8 0.25
M41 Primary 48.5 60.9 13.1 4.65
Secondary 15.7 16.1 30.3 0.53
Tertiary 1.2 5.6 32.9 0.17
M19 Primary 22.8 21.9 28.6 0.77
Secondary 8.5 13.6 36.4 0.37
Tertiary 4.9 12.7 51.5 0.25
Median Primary (N=13) 52.3 45.4 21.2 2.38
LQ-UQ 32.0–65.8 26.5–57.7 17.4–28.5 1.50–2.90
Median Secondary (N=13) 15.7 20.5 30.9 0.65
LQ-UQ 7.7–32.0 16.7–23.8 26.7–37.9 0.46–0.92
Median Tertiary (N=7) 3.6 17.6 40.8 0.25
LQ-UQ 1.8–6.4 10.4–21.9 34.4–50.3 0.24–0.55
Wilcoxon-paired Prim vs sec (N=13) P<0.01 P<0.01 P<0.01 P<0.01
Prim vs sec (N=7) P<0.05 NS P<0.05 P<0.05
Prim vs tert (N=7) P<0.05 P<0.05 P<0.05 P<0.05
Differences between primary (prim) and secondary (sec) cultures were analyzed for the total group (N=13) and
for the chondrocytes of seven donors that were subcultured twice. LQ-UQ: lower quartile–upper quartile; CII/CI:
type II/type I collagen ratio; NS: not significant.RE-EXPRESSION OF CELL MEMBRANE-BOUND EXTRACELLULAR
MATRIX ANTIGENS BY DEDIFFERENTIATED CHONDROCYTES
IN VITRO
Re-expression of cell membrane-bound extracellular
matrix antigens by isolated articular cartilage cells in-vitro
was assayed in monolayer and agarose culture. Primary
monolayer-cultured chondrocytes were released with
1 mmol/l EDTA in HBSS without Ca+ +/Mg+ + from the
culture dishes after 8 days of culture. The procedure
allowed the chondrocytes to be phenotyped. Cell
membrane-bound extracellular matrix molecules were then
removed by trypsin digestion [0.1% (w/v) of trypsin in HBSS
without Ca+ +/Mg+ +]. Subsequently, the ‘naked’ cells were
subcultured in either the monolayer condition or in gelled
agarose. Re-expression of the cell-bound antigens wasmonolayer culture over a period of 4 weeks [Fig. 3(A)].
After the enzymatic isolation from the cartilage matrix,
none of the ECM molecules could be detected on the
cell surface. The cells appeared to show a tendency to
re-express the original ECM macromolecules during the
first few days in culture. However, after prolonged culture in
monolayer, increasing proportions of the chondrocytes
failed to accumulate the original ECM compounds and type
I collagen became the major collagen in the pericellular
zone.
Re-expression of the original phenotype by primary
chondrocytes in suspension culture was confirmed when
these cells were followed over a 28-day period [Fig. 3(B)].
However, synthesis of unusual type I collagen accompa-
nies differentiation of the articular cartilage cell in gelled
agarose.
Osteoarthritis and Cartilage Vol. 9 No. 1 81studied by flow cytometry after different periods of time for
6 days. Monolayer cultured cells were therefore liberated
from the dishes with EDTA, and chondrocytes in agarose
were isolated from the gel using agarase. The results of this
experiment are presented in Table VIII. There was loss of
expression of the cartilage-specific aggrecan in secondary
monolayer culture, whereas almost 80% of the cells
re-expressed this macromolecule when subcultured in
agarose. Although less pronounced, there was a similar
observation with type II collagen. Type I collagen tended to
become the major collagen in monolayer-cultured chondro-
cytes. Significant amounts of type I collagen were also
produced by the cells when subcultured in agarose.Table VII
Comparison of chondrocyte phenotype in agarose and in monolayer culture
Male/female, age Culture Percentage of cells expressing CII/CI
Aggrecan Collagen II Collagen I
F55 Agarose 82.8 54.8 11.2 4.89
Monolayer 66.2 14.4 25.9 0.56
F27 Agarose 56.2 35.3 21.9 1.61
Monolayer 33.1 27.3 30.9 0.88
M31 Agarose 77.3 69.5 17.3 4.02
Monolayer 65.6 48.8 28.4 1.72
M40 Agarose 53.0 46.0 5.0 9.20
Monolayer 24.4 24.1 8.6 2.80
M23 Agarose 68.8 78.5 29.6 2.65
Monolayer 52.3 43.8 18.4 2.38
M19 Agarose 87.1 57.7 24.7 2.24
Monolayer 22.8 21.9 28.7 0.76
M25 Agarose 67.1 59.5 17.4 3.42
Monolayer 28.7 14.4 21.2 0.68
M41 Agarose 48.5 60.9 13.1 4.65
Monolayer 30.9 22.4 27.5 0.81
Median Agarose 67.9 58.6 17.4 3.72
LQ-UQ 54.6–80.1 50.4–65.2 12.2–23.3 2.50–4.77
Median Monolayer 32.0 23.3 26.7 0.84
LQ-UQ 26.6–59.0 18.2–35.6 19.8–28.6 0.72–2.05
Wilcoxon-paired P<0.01 P<0.01 NS P<0.01
CII/CI: type II/type I collagen ratio; LQ-UQ: lower quartile–upper quartile.Discussion
Preservation of the original chondrocyte phenotype is a
condition sine qua non for investigation on homeostasis
of the intercellular matrix by articular cartilage cells.
Methods for assessing chondrocyte phenotype may
provide researchers with some control of this variable.
Immunohistochemical methods have been used in a pilot
study to characterize the phenotypic changes of
monolayer-cultured human articular cartilage cells in differ-
ent conditioned growth media.21 The use of monoclonal
antibodies directed against different extracellular matrix
compounds in flow cytometric assays was also shown to be
a useful tool with which to study articular cartilage cell
phenotype.39
Flow cytometry allows study of the composition of the
CAM. The CAM is a part of the pericellular or territorial
matrix of the cell. The distribution and turnover of the
contents of the extracellular matrix are different in the
territorial and in the adjacent interterritorial matrix (ITM).40
The contents of the ITM, e.g. chondrocyte-specific aggre-
can and type II collagen, are often considered to define
chondrocyte phenotype. However, these ITM molecules
hardly reflect the ‘instant phenotype’ of the cells given theirlow turnover rates. Half-life times of 400–800 days have
been reported for aggrecan in-vivo41 and, compared with
other body proteins, collagen in normal adult human carti-
lage showed no or minimal turnover.42,43 These differences
in synthesis and turnover rates also exist in most in-vitro
culture models. When ITM molecules are studied in in-vitro
models to assess de- or redifferentiation, and nonradio-
active tracer methods are used, most probably ‘old’
molecules from cells that have already disappeared from
the scene will be picked up. Hence, ITM molecules poorly
define the ‘instant chondrocyte phenotype’.
Our experiments were performed to investigate the de
novo expression of cell-associated ECM molecules. The
cells isolated either from articular cartilage after enzyme
digestion or from monolayer culture after trypsinization
(subcultures) were totally depleted of their CAM molecules
since all the ECM proteins had been removed by the
enzymes. We have shown that the ECM molecules were
re-expressed during cell culture within 12 h by variable
proportions of the cells. These ECM molecules reside on
the plasma membrane (CAM) for short periods of time. The
neosynthesized cell-associated molecules have been
shown to leave the territorial matrix at a later stage, and to
diffuse to the interterritorial matrix.40 The biochemical com-
position of the CAM therefore more realistically reflects the
instant phenotype of cells cultured in different culture
conditions.
Monolayer-cultured cells showed a remarkably different
morphology and production of extracellular matrix macro-
molecules when cultured in the presence or absence of
serum. When attached on polylysine-coated culture dishes
and maintained in serum-free conditions in the presence of
insulin, transferrin and TGF-β, the cells characteristically
grew in clusters. Immunocytochemical staining showed full
preservation of the chondrocyte phenotype. When main-
tained in FCS-containing DMEM, the chondrocytes rapidly
lost their original morphology.
Proportions of chondrocytes producing the different
ECM macromolecules were easily quantiﬁed using ﬂow
cytometry. Isolation of the chondrocytes from the mono-
layers or from the agarose gel did not affect their surround-
ing cell-bound matrix since treatment of the cells with
agarase or EDTA did not alter the expression of the
cell-bound matrix antigens. The ﬂow cytometry technique
was reproducible and the procedure was shown to be
reliable.
Although type I collagen synthesis was observed by
approximately 17% of the primary cultured chondrocytes in
gelled agarose, the cartilage-speciﬁc aggrecan and type II
collagen were produced by about 68% and 59% of the
cells, respectively, indicating expression of the original
chondrocyte phenotype in this culture condition. Stability of
the original phenotype of primary chondrocytes in suspen-
sion culture was conﬁrmed when these cells were followed
over longer periods of time. Signiﬁcant variations in the
percentages of cells staining for both the chondrocyte-
speciﬁc ECM antigens were observed where chondrocytes
obtained from different donors were studied. The expres-
sion of cell-associated ECM molecules depends on the
balance of synthesis and release of these molecules into
the territorial or interterritorial matrix. The rate of de novo
biosynthesis of different ECM macromolecules in-vivo is
different41–43 and these differences are probably main-
tained in in-vitro conditions. Aggrecan in these in-vitro
experiments was more rapidly expressed than collagen.
The fact that some of the cells did not express collagen
within the short periods of culture is not surprising. More-
over, the release of the CAM components can take place
within short periods of time.40 Collagen may not be as
strongly attached to its cell membrane receptor as aggre-
can and may leave its plasma membrane receptor more
easily and diffuse to the ITM.
Redifferentiation of dedifferentiated chondrocytes was
characterized by a re-expression of the original extra-
cellular matrix compounds. However, synthesis of the
unusual type I collagen accompanied redifferentiation of
the articular cartilage cell in gelled agarose. The suggestion
that synthesis of type I collagen indicates loss of the
chondrocyte phenotype and dedifferentiation to a ﬁbrobast-
like cell should be re-evaluated. It has been proposed that
the loss of chondrocyte phenotype is marked by the loss of
one or more cartilage-speciﬁc components rather than by
the appearance of non-cartilage-speciﬁc molecules.44
Fig. 3. Re-expression of cell membrane-bound extracellular matrix
antigens by chondrocytes in secondary culture. (A) monolayer-
cultured chondrocytes. (B) chondrocytes in gelled agarose.
Ordinates: % of positive cells. Abscissa: culture time in days.
Table VIII
Re-expression of cell membrane-bound extracellular matrix antigens in-vitro
Culture/time Percentage of cells expressing CII/CI
Aggrecan Collagen II Collagen I
Primary monolayer 57.7 54.9 12.9 4.25
After removal of ECM 1.2 2.0 1.5 n.a.
Secondary culture
Monolayer 12 h 3.4 20.5 10.8 1.89
1 day 7.2 31.5 28.2 1.12
2 days 11.9 32.8 30.0 1.09
4 days 8.4 41.3 32.1 1.29
6 days 7.9 29.2 30.9 0.94
Agarose 12 h 25.7 26.4 18.2 1.45
1 day 28.2 30.4 26.5 1.15
2 days 65.2 53.8 39.4 1.37
4 days 66.7 63.4 41.6 1.52
6 days 80.5 67.0 40.7 1.65
CII/CI: type II/type I collagen ratio; n.a.: not applicable.
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chondrocytes in primary monolayer cultures and chondro-
cytes cultured in gelled agarose. Culture and subculture of
the cartilage cells in the monolayer condition in the pres-
ence of serum showed both plasma membrane-bound
aggrecan and type II collagen expressed in significantly
decreasing proportions of the chondrocytes. Increasing
proportions of chondrocytes expressed type I collagen after
a first passage. The mean ratio of type II/I decreased
accordingly. These changes became more pronounced
when tertiary cultures were investigated as well as in
primary chondrocytes cultured in the monolayer condition
for prolonged periods of time. Much more than variations
in cell-bound collagens, changes in aggrecan reflected
maintenance or loss of the original chondrocyte phenotype.
In summary, flow cytometric analysis of the cell-
associated matrix of articular cartilage chondrocytes offers
a reproducible and reliable method for studying chondro-
cyte phenotype in different culture conditions. The results
obtained confirmed how chondrocyte biology is conditioned
in various experimental conditions and contributed to the
validation of flow cytometry as a tool with which to study
the CAM. The plasma membrane-associated matrix
occupies a key position in the organization of the cell-
extracellular matrix junction in articular cartilage. Studies
on the cell-associated extracellular matrix may provide
additional information on the pathology of inflammatory and
degenerative connective tissue diseases. A continuously
increasing number of specific monoclonal antibodies will
broaden the range of applications offered by this method.
Similar results may have been obtained with other
methods, e.g. immunohistochemistry followed by image
analysis, in situ hybridization. However, flow cytometry
offers some advantages. It offers the possibility of testing a
large number of epitopes on a large number of single cells
within a short period of time and allows the study of
epitopes inside as well as outside cells. Finally, synthesis
and catabolism of the ECM molecules is reflected by
changes in the number of these molecules in the CAM.
These changes can be monitored by flow cytometry since
the technique allows the packing of an antigen in the CAM
of a cell population to be quantified by measuring its mean
fluorescence intensity due to the binding of the specific
monoclonal antibodies used. Assessment of the mean
fluorescence intensity of the cells thus offers quantifi-
cation of the synthesis and accumulation of the ECM
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